J. Crew posts better-than-expected 4Q results

This version of Wbna26410753 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.

Apparel maker J. Crew Group Inc. on Tuesday reported a fiscal fourth-quarter loss on lower demand, but results were better than analysts had predicted, sending shares up 10 percent in aftermarket trading.

Apparel maker J. Crew Group Inc. on Tuesday reported a fiscal fourth-quarter loss on lower demand, but results were better than analysts had predicted, sending shares up 10 percent in aftermarket trading.

Losses for the three months ended Jan. 31 totaled $13.5 million, or 22 cents per share, compared with a year-ago profit of $25 million, or 39 cents per share, last year. Excluding impairment charges, the latest-quarter loss totaled 20 cents per share.

Revenue fell 3 percent to $388 million from $399.9 million last year.

But the results topped expectations of analysts polled by Thomson Reuters, who on average predicted a wider loss of 27 cents per share on revenue of $372.8 million. Analyst estimates typically exclude one-time charges.

The company itself had forecast a wider loss between 24 cents and 29 cents per share.

Demand for J.Crew's preppy clothing has dropped amid the recession and consumer spending pullback. Late last month the company said it would cut jobs, eliminate merit-based wage increases and suspend its 401(k) matching contribution plan through the rest of the year to shore up costs.

Millard Drexler, company chief executive, said in a statement J. Crew is adjusting to the "new, not fun, retail reality."

For the year, profit fell 44 percent to $54.1 million, or 85 cents per share, from $97.1 million, or $1.52 per share, a year ago. But revenue rose 7 percent to $1.42 billion from $1.33 billion last year.

The company forecast first-quarter adjusted earnings between 7 and 12 cents per share, down sharply from last year's 48-cent profit but still in range of analysts' average forecast of 10 cents per share.

Shares rose 36 cents, or 3.9 percent, to close earlier at $9.72, and jumped 98 cents to $10.70 in after-hours electronic trading.

AdBlock Detected!
Please disable it to support our content.
×

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Joe Biden Campaign News - Politics and Government | NBC News Clone | Kamala Harris Vp Announcement - Politics and Government | NBC News Clone | Trump Indictment Latest - Politics and Government | NBC News Clone | Election Results Live - Politics and Government | NBC News Clone | Swing States Polling - Politics and Government | NBC News Clone | Debate Highlights - Politics and Government | NBC News Clone | Budget Approval 2025 - Politics and Government | NBC News Clone | Abortion Ruling - Politics and Government | NBC News Clone | Us China Relations - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Federal Reserve Interest Rates - Business and Economy | NBC News Clone | Stock Market Today - Business and Economy | NBC News Clone | Recession Prediction 2025 - Business and Economy | NBC News Clone | Jobs Report Unemployment - Business and Economy | NBC News Clone | Ai Stock Surge - Business and Economy | NBC News Clone | Housing Market Crash - Business and Economy | NBC News Clone | Oil Prices Update - Business and Economy | NBC News Clone | Amazon Prime Sales - Business and Economy | NBC News Clone | Bitcoin Etf Approval - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Covid Variants Update - Health and Medicine | NBC News Clone | Boosters New Guidelines - Health and Medicine | NBC News Clone | Anxiety Depression Treatment - Health and Medicine | NBC News Clone | Longevity Research - Health and Medicine | NBC News Clone | Diet Trends 2025 - Health and Medicine | NBC News Clone | Workout Routines - Health and Medicine | NBC News Clone | Fda Approvals 2025 - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Israel Palestine War News - World News | NBC News Clone | China Taiwan Tensions - World News | NBC News Clone | Middle East Peace Talks - World News | NBC News Clone | European Union Politics - World News | NBC News Clone | Development News - World News | NBC News Clone | North Korea Missile Test - World News | NBC News Clone | Brazil Election - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | Google Bard Ai - Technology and Innovation | NBC News Clone | Ai Regulation Laws - Technology and Innovation | NBC News Clone | Tiktok Ban Update - Technology and Innovation | NBC News Clone | Data Breaches 2025 - Technology and Innovation | NBC News Clone | Iphone 16 Release - Technology and Innovation | NBC News Clone | Nasa Mars Mission - Technology and Innovation | NBC News Clone | Web3 Developments - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Super Bowl 2025 Preview - Sports and Recreation | NBC News Clone | Nba Playoffs 2025 - Sports and Recreation | NBC News Clone | Champions League Finals - Sports and Recreation | NBC News Clone | World Series 2025 - Sports and Recreation | NBC News Clone | Masters Tournament 2025 - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hurricane Season 2025 - Weather and Climate | NBC News Clone | Global Warming Report - Weather and Climate | NBC News Clone | Weekly Weather Update - Weather and Climate | NBC News Clone | Earthquake Alerts - Weather and Climate | NBC News Clone | Solar Storm Warning - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Oscar Nominations 2025 - Entertainment and Celebrity | NBC News Clone | Grammy Awards 2025 - Entertainment and Celebrity | NBC News Clone | Netflix New Releases - Entertainment and Celebrity | NBC News Clone | Video Game Releases - Entertainment and Celebrity | NBC News Clone | Bestseller List - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Political Corruption - Investigations and Analysis | NBC News Clone | Big Tech Monopoly - Investigations and Analysis | NBC News Clone | Data Privacy Scandal - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone | Nyc Mayor News - Local News and Communities | NBC News Clone | La Wildfires Update - Local News and Communities | NBC News Clone | Hurricane Preparedness - Local News and Communities | NBC News Clone